성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Antithyroid Medications | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Antithyroid Medications

NCLEX Review Guide: Antithyroid Medications

Antithyroid Medication Overview

Primary Antithyroid Agents

  • Methimazole (Tapazole) is the first-line antithyroid medication that blocks thyroid hormone synthesis by inhibiting thyroid peroxidase enzyme. It has a longer half-life than PTU, allowing for once-daily dosing and better patient compliance.
  • Propylthiouracil (PTU) blocks thyroid hormone synthesis and peripheral conversion of T4 to T3. It's preferred during pregnancy (first trimester) and thyroid storm due to its additional action of blocking peripheral hormone conversion.
  • Radioactive Iodine (I-131) destroys thyroid tissue through radiation, providing permanent treatment for hyperthyroidism. Patients become hypothyroid and require lifelong thyroid hormone replacement therapy.

Key Points

  • Methimazole is preferred for most patients except pregnant women in first trimester
  • PTU requires multiple daily doses due to shorter half-life
  • Both medications can cause agranulocytosis as a serious adverse effect

Critical Nursing Considerations

Serious Adverse Effects

  • Agranulocytosis is a life-threatening decrease in white blood cells that occurs in 0.1-0.5% of patients taking antithyroid medications. Monitor for signs of infection including fever, sore throat, mouth ulcers, and fatigue.
  • Hepatotoxicity is more common with PTU than methimazole, requiring regular liver function monitoring. Patients should report jaundice, dark urine, light-colored stools, or abdominal pain immediately.
  • Hypothyroidism can develop from overtreatment, requiring dose adjustment based on TSH and T4 levels. Symptoms include fatigue, weight gain, cold intolerance, and bradycardia.

Memory Aid: "WATCH" for Antithyroid Side Effects

WBC decrease (agranulocytosis)
Agranulocytosis signs
Thyroid levels (monitor regularly)
Cold intolerance (hypothyroid symptoms)
Hepatotoxicity (especially PTU)

Patient Monitoring and Education

Essential Monitoring Parameters

  1. Obtain baseline complete blood count (CBC) before initiating therapy to establish normal WBC count
  2. Monitor thyroid function tests (TSH, T3, T4) every 4-6 weeks initially, then every 2-3 months once stable
  3. Assess liver function tests, especially with PTU therapy, at baseline and periodically during treatment
  4. Evaluate patient for signs of infection or bleeding due to potential bone marrow suppression

Clinical Scenario

A 35-year-old female taking methimazole for Graves' disease calls reporting fever (101.2°F), severe sore throat, and mouth sores for 2 days. This requires immediate medical evaluation as these symptoms suggest possible agranulocytosis. Discontinue medication and obtain stat CBC with differential.

Commonly Confused Concepts

AspectMethimazolePTU
Dosing FrequencyOnce daily2-3 times daily
Pregnancy SafetyCategory D (avoid first trimester)Preferred in pregnancy
Hepatotoxicity RiskLowerHigher
Thyroid StormNot preferredPreferred (blocks conversion)
Half-life4-6 hours1-2 hours

Quick Check: Common Pitfalls

  • Don't confuse antithyroid medications with thyroid replacement therapy
  • Remember PTU is preferred in pregnancy and thyroid storm, not methimazole
  • Both medications can cause agranulocytosis - monitor for infection signs

Study Tips and Memory Aids

Memory Aid: "PTU for Pregnant and Thyroid storm"

Remember PTU is preferred in two specific situations: Pregnancy and thyroid storm (Thyroid storm). For all other situations, methimazole is typically first-line.

Dosing Memory Aid: "Meth Once, PTU Multiple"

Methimazole = Once daily dosing
PTU = Multiple times daily (2-3x)

Self-Assessment Checklist

  • I can identify the two main antithyroid medications and their key differences
  • I understand when to use PTU versus methimazole
  • I can recognize signs of agranulocytosis and appropriate nursing actions
  • I know the monitoring parameters for patients on antithyroid therapy
  • I can explain patient education points for antithyroid medications

You're mastering complex pharmacology concepts! Remember, understanding the "why" behind antithyroid therapy helps you provide safer patient care. Keep connecting the pathophysiology to the medications - you've got this! 🌟

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.